Communiqués Medtronic plc

Actions

MDT

IE00BTN1Y115

Marché Fermé - Nyse Autres places de cotation 22:00:02 31/05/2024			Varia. 5j.	Varia. 1 janv.
81,37 ^USD	+0,96 %		-1,12 %	-1,23 %

31/05	Cosmo dégage une perte en 2023, mais versera tout de même un dividende	AW
30/05	MEDTRONIC PLC : Daiwa Securities persiste à l'achat	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Medtronic announces pricing of €3.0 billion of senior notes	29/05	PR
Medtronic : Proposed Infuse™ TLIF indication granted Breakthrough Device designation by FDA	29/05	PU
Medtronic : Emily Elswick named president of Medtronic Pelvic Health business	28/05	PU
Medtronic : names Linnea Burman SVP & president of the neurovascular business	28/05	PU
Medtronic : Covidien Japan and HOGY Medical conclude a service agreement to commence cooperation on the sale of SuReFInD®	24/05	PU
Medtronic : Fourth Quarter 2024 Financial Commentary	23/05	PU
Medtronic : Fourth Quarter 2024 Release	23/05	PU
Medtronic : Fourth Quarter 2024 Presentation	23/05	PU
Medtronic : Fourth Quarter 2024 Financial Statements	23/05	PU
Medtronic: Fiscal Q4 Earnings Snapshot	23/05	AQ
Medtronic : announces clinical studies underway for two additional indications for Hugo™ RAS system in the U.S.	23/05	PU
Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase	23/05	AQ
Medtronic : VERITAS study shows Medtronic fluoroscopic navigation platform offers a safer lung biopsy experience and the same diagnostic yield as CT-guided biopsy	22/05	PU
MiniMed™ 780G system recognized among Fast Company's 2024 World Changing Ideas	20/05	PR
Medtronic Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment	20/05	AQ
Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment	17/05	PR
Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™	17/05	PR
Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™	17/05	AQ
Medtronic : PulseSelect™ pulsed field ablation system receives approval in Japan, broadening global impact of paradigm-shifting AFib treatment	10/05	PU
Medtronic to announce financial results for its fourth quarter and full fiscal year 2024	09/05	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Medtronic plc : Réfugié derrière son statut d'aristocrate du dividende

Le 27 mai 2024 à 11:05